Loading clinical trials...
Loading clinical trials...
A Non-randomized, Open-label Study to Investigate the Effects of Imatinib Mesylate on the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Conditions
Interventions
Imatinib/Acetaminophen
Locations
1
South Korea
Novartis Investigative Site
Seoul, South Korea
Start Date
November 1, 2006
Primary Completion Date
August 1, 2008
Completion Date
August 1, 2008
Last Updated
April 21, 2016
NCT06514534
NCT05589896
NCT02790515
NCT03746054
NCT06865443
NCT01667133
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions